相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Modulation of T-Cell Activation by Malignant Melanoma Initiating Cells
Tobias Schatton et al.
CANCER RESEARCH (2010)
Survival of Patients with Newly Diagnosed Glioblastoma Treated with Radiation and Temozolomide in Research Studies in the United States
Stuart A. Grossman et al.
CLINICAL CANCER RESEARCH (2010)
被撤回的出版物: Glioma-Associated Cancer-Initiating Cells Induce Immunosuppression (Retracted article. See vol. 21, pg. 2189, 2015)
Jun Wei et al.
CLINICAL CANCER RESEARCH (2010)
Immunobiological Characterization of Cancer Stem Cells Isolated from Glioblastoma Patients
Tiziano Di Tomaso et al.
CLINICAL CANCER RESEARCH (2010)
Vaccine provides new hope for patients with deadly brain cancer
[Anonymous]
FUTURE NEUROLOGY (2010)
Glioblastoma Cancer-Initiating Cells Inhibit T-Cell Proliferation and Effector Responses by the Signal Transducers and Activators of Transcription 3 Pathway
Jun Wei et al.
MOLECULAR CANCER THERAPEUTICS (2010)
The transcriptional network for mesenchymal transformation of brain tumours
Maria Stella Carro et al.
NATURE (2010)
Glioma cancer stem cells induce immunosuppressive macrophages/microglia
Adam Wu et al.
NEURO-ONCOLOGY (2010)
Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
F. Stephen Hodi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Immunologic Escape After Prolonged Progression-Free Survival With Epidermal Growth Factor Receptor Variant III Peptide Vaccination in Patients With Newly Diagnosed Glioblastoma
John H. Sampson et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Brain metastases and subtypes of breast cancer
B. C. Pestalozzi
ANNALS OF ONCOLOGY (2009)
Clinical benefit in Phase-I trials of novel molecularly targeted agents: does dose matter?
S. Postel-Vinay et al.
BRITISH JOURNAL OF CANCER (2009)
Recognition and Killing of Brain Tumor Stem-Like Initiating Cells by CD8+ Cytolytic T Cells
Christine E. Brown et al.
CANCER RESEARCH (2009)
Efficacy of temozolomide as adjuvant chemotherapy after postsurgical radiotherapy alone for glioblastomas
Deok-Joo Rhee et al.
CLINICAL NEUROLOGY AND NEUROSURGERY (2009)
Tumor-associated macrophages and the related myeloid-derived suppressor cells as a paradigm of the diversity of macrophage activation
Alberto Mantovani et al.
HUMAN IMMUNOLOGY (2009)
Self-antigen-specific CD8+ T cell precursor frequency determines the quality of the antitumor immune response
Gabrielle A. Rizzuto et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2009)
Tuberculosis Subunit Vaccination Provides Long-Term Protective Immunity Characterized by Multifunctional CD4 Memory T Cells
Thomas Lindenstrom et al.
JOURNAL OF IMMUNOLOGY (2009)
A phase II clinical trial of poly-ICLC with radiation for adult patients with newly diagnosed supratentorial glioblastoma: a North American Brain Tumor Consortium (NABTC01-05)
Nicholas Butowski et al.
JOURNAL OF NEURO-ONCOLOGY (2009)
An epidermal growth factor receptor variant III-targeted vaccine is safe and immunogenic in patients with glioblastoma multiforme
John H. Sampson et al.
MOLECULAR CANCER THERAPEUTICS (2009)
Lessons from 60 years of pharmaceutical innovation
Bernard Munos
NATURE REVIEWS DRUG DISCOVERY (2009)
Anti-CTLA-4 therapy-related autoimmune hypophysitis in a melanoma patient
Katharina C. Kaehler et al.
MELANOMA RESEARCH (2009)
Modulation of Angiogenic and Inflammatory Response in Glioblastoma by Hypoxia
Anastasia Murat et al.
PLOS ONE (2009)
Antigen-Specific T-Cell Response from Dendritic Cell Vaccination Using Cancer Stem-Like Cell-Associated Antigens
Qijin Xu et al.
STEM CELLS (2009)
Vaccination elicits correlated immune and clinical responses in glioblastoma multiforme patients
Christopher J. Wheeler et al.
CANCER RESEARCH (2008)
A novel inhibitor of signal transducers and activators of transcription 3 activation is efficacious against established central nervous system melanoma and inhibits regulatory T cells
Ling-Yuan Kong et al.
CLINICAL CANCER RESEARCH (2008)
Incidence and prognostic impact of FoxP3+ regulatory T cells in human gliomas
Amy B. Heimberger et al.
CLINICAL CANCER RESEARCH (2008)
Postoperative adjuvant dendritic cell-based immunotherapy in patients with relapsed glioblastoma multiforme
Steven De Vleeschouwer et al.
CLINICAL CANCER RESEARCH (2008)
Stem cell-related Self-Renewal signature and high epidermal growth factor receptor expression associated with resistance to concomitant chemoradiotherapy in glioblastoma
Anastasia Murat et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Tumor-infiltrating myeloid-derived suppressor cells are pleiotropic-inflamed monocytes/macrophages that bear M1- and M2-type characteristics
Naoki Umemura et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2008)
Tumor antigen precursor protein profiles of adult and pediatric brain tumors identify potential targets for immunotherapy
Jian Gang Zhang et al.
JOURNAL OF NEURO-ONCOLOGY (2008)
CTLA-4 blockade enhances polyfunctional NY-ESO-1 specific T cell responses in metastatic melanoma patients with clinical benefit
Jianda Yuan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
T-cell quality in memory and protection: implications for vaccine design
Robert A. Seder et al.
NATURE REVIEWS IMMUNOLOGY (2008)
Brain microenvironment promotes the final functional maturation of tumor-specific effector CD8+ T cells
Frederick Masson et al.
JOURNAL OF IMMUNOLOGY (2007)
CD4+CD25+FoxP3+ T-cell infiltration and heme oxygenase-1 expression correlate with tumor grade in human gliomas
Abdeljabar El Andaloussi et al.
JOURNAL OF NEURO-ONCOLOGY (2007)
Loss of tumor suppressor PTEN function increases B7-H1 expression and immunoresistance in glioma
Andrew T. Parsa et al.
NATURE MEDICINE (2007)
Ratio of trastuzumab levels in serum and cerebrospinal fluid is altered in HER2-positive breast cancer patients with brain metastases and impairment of blood-brain barrier
Hans-Joachim Stemmler et al.
ANTI-CANCER DRUGS (2007)
Enhanced survival associated with vitiligo expression during maintenance biotherapy for metastatic melanoma
Peter D. Boasberg et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2006)
Cellular immune responses in children and adults receiving inactivated or live attenuated influenza vaccines
Xiao-Song He et al.
JOURNAL OF VIROLOGY (2006)
Phase I clinical trial of a TGF-β antisense-modified tumor cell vaccine in patients with advanced glioma
H. Fakhrai et al.
CANCER GENE THERAPY (2006)
T cells traffic from brain to cervical lymph nodes via the cribroid plate and the nasal mucosa
Jana Goldmann et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2006)
Cytokine storm in a phase 1 trial of the anti-CD28 monoclonal antibody TGN1412
Ganesh Suntharalingam et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
IL-2 regulates FOXP3 expression in human CD4+CD25+ regulatory T cells through a STAT-dependent mechanism and induces the expansion of these cells in vivo
Emmanuel Zorn et al.
BLOOD (2006)
The role of glioma microenvironment in immune modulation: Potential targets for intervention
Mahua Dey et al.
LETTERS IN DRUG DESIGN & DISCOVERY (2006)
Antigen-specific T-cell-mediated immunity after HIV-1 infection: implications for vaccine control of HIV development
Michael R. Betts et al.
EXPERT REVIEW OF VACCINES (2006)
Systemic anti-CD25 monoclonal antibody administration safely enhances immunity in murine glioma without eliminating regulatory T cells
Peter E. Fecci et al.
CLINICAL CANCER RESEARCH (2006)
Placebo-controlled phase III trial of immunologic therapy with sipuleucel-T (APC8015) in patients with metastatic, asymptomatic hormone refractory prostate cancer
Eric J. Small et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
The role of human glioma-infiltrating microglia/macrophages in mediating antitumor immune responses
S. Farzana Hussain et al.
NEURO-ONCOLOGY (2006)
An increase in CD4+CD25+FOXP3+ regulatory T cells in tumor-infiltrating lymphocytes of human glioblastoma multiforme
Abdejabar El Andaloussi et al.
NEURO-ONCOLOGY (2006)
HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells
Michael R. Betts et al.
BLOOD (2006)
Increased regulatory T-cell fraction amidst a diminished CD4 compartment explains cellular immune defects in patients with malignant glioma.
PE Fecci et al.
CANCER RESEARCH (2006)
Prognostic significance of autoimmunity during treatment of melanoma with interferon
H Gogas et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Low surface expression of B7-1 (CD80) is an immunoescape mechanism of colon carcinoma
I Tirapu et al.
CANCER RESEARCH (2006)
Clinical experience with denileukin diftitox (ONTAK)
F Foss
SEMINARS IN ONCOLOGY (2006)
CD28-mediated costimulation impacts on the differentiation of DC vaccination-induced T cell responses
H Voigt et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2006)
Inhibiting Stat3 signaling in the hematopoietic system elicits multicomponent antitumor immunity
M Kortylewski et al.
NATURE MEDICINE (2005)
Inability of a fusion protein of IL-2 and diphtheria toxin (Denileukin Diftitox, DAB389IL-2, ONTAK) to eliminate regulatory T lymphocytes in patients with melanoma
P Attia et al.
JOURNAL OF IMMUNOTHERAPY (2005)
Immunologic evaluation of personalized peptide vaccination for patients with advanced malignant glioma
N Yajima et al.
CLINICAL CANCER RESEARCH (2005)
Dendritic cell vaccination in glioblastoma patients induces systemic and intracranial T-cell responses modulated by the local central nervous system tumor microenvironment
LM Liau et al.
CLINICAL CANCER RESEARCH (2005)
Characterization of functional and phenotypic changes in anti-Gag vaccine-induced T cell responses and their role in protection after HIV-1 infection
MR Betts et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
R Stupp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
A pooled analysis of Eastern Cooperative Oncology Group and Intergroup trials of adjuvant high-dose interferon for melanoma
JM Kirkwood et al.
CLINICAL CANCER RESEARCH (2004)
Selective CD4+ lymphopenia in melanoma patients treated with temozolomide:: A toxicity with therapeutic implications
YB Su et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Gene expression profiling of gliomas strongly predicts survival
WA Freije et al.
CANCER RESEARCH (2004)
STAT3 activation in macrophages following infection with Salmonella
T Lin et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival
TJ Curiel et al.
NATURE MEDICINE (2004)
Vaccination with tumor lysate-pulsed dendritic cells elicits antigen-specific, cytotoxic T-cells in patients with malignant glioma
JS Yu et al.
CANCER RESEARCH (2004)
Naturally arising CD4(+) regulatory T cells for immunologic self-tolerance and negative control of immune responses
S Sakaguchi
ANNUAL REVIEW OF IMMUNOLOGY (2004)
Pubertal changes in biochemical markers of growth
G Federico et al.
HORMONE RESEARCH (2003)
Shaping gene expression in activated and resting primary macrophages by IL-10
R Lang et al.
JOURNAL OF IMMUNOLOGY (2002)
Regulation of T-cell responses by CNS antigen-presenting cells: different roles for microglia and astrocytes
F Aloisi et al.
IMMUNOLOGY TODAY (2000)
分享论文
